Annual Report on Form 10-K

The report describes Twist Bioscience's fiscal 2021 revenue rising 47% to $132.3 million as its synthetic DNA and NGS business expanded. It reports 652 employees and women comprising 30% of the board. On environmental efficiency, the company says its platform can achieve at least a 99.8% reduction in chemical consumption compared with legacy oligo synthesis, while its integrated workflow produces nearly zero wasted synthesized oligos.